HK1 and myelodysplastic syndrome: Although research on HK levels in MDS cells is limited, HK inhibitors [e.g., 3-Bromopyrvate (3-BrPA) and 2-Deoxy-D-glucose (2-DG)] have shown anti-tumor effects [80].